Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 10Observational 2

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 7Pancreatic Neoplasms 3Stomach Neoplasms 2Recurrence 2Neoplasms 2Nasopharyngeal Carcinoma 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Peritoneal Neoplasms 1Neutropenia 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Muscle Neoplasms 1Mesothelioma 1Locally Advanced Pancreatic Adenocarcinoma 1Liver Neoplasms 1Keratosis, Actinic 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1Chronic Pain 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Breast Cancer Organoids 1

Interventions

Surgical Procedures, Operative 7Liver Transplantation 5Lenalidomide 4Blood Specimen Collection 4pomalidomide 3Neoadjuvant Therapy 3Liquid Biopsy 3gilteritinib 2Therapeutics 2Rituximab 2Proteasome Inhibitors 2Observation 2Mohs Surgery 2Mitomycin 2Magnetic Resonance Spectroscopy 2Immunotherapy, Adoptive 2Immunoconjugates 2High-Throughput Nucleotide Sequencing 2Fluorouracil 2Drug Therapy 2DNA, Mitochondrial 2Brentuximab Vedotin 2Bendamustine Hydrochloride 2Antibodies, Monoclonal 2Antibodies, Bispecific 2Amplified Fragment Length Polymorphism Analysis 2trametinib 1romidepsin 1nedaplatin 1lenvatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Recurrence × Fluorouracil × Clear all
NCT02207660 2015-02-05

Cisplatin Plus One-Day 24-hour Infusion of High-Dose 5-Fluorouracil for Stage IVB, Recurrent or Metastatic Carcinoma of the Uterine Cervix

National Taiwan University Hospital

Completed
30 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence

NCT00644020 2008-03-26

Phase â…¡Study of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients

Shenzhen Kangzhe Pharmaceutical Co., Ltd.

Unknown
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡